
Please try another search
By Vlad Schepkov
Morgan Stanley analyst Pamela Kaufman upgraded Altria Group (NYSE:MO) to “Equal-weight” rating from “Underweight” citing recent underperformance and a more “balanced risk-reward” but cut the price target to $43 from $47 following the FDA’s ban on Juul's line of products.
The analyst comments that despite persisting concerns over "MO's fundamentals and long-term structural positioning”, the recent sharp pullback – the stock is down over 21% in June alone, vs an 8% drop in the S&P 500 – means “the market is more appropriately pricing in our concerns."
She thus sees the current lower valuation, having contracted "from 8.6x to 7.3x NTM EV/EBITDA (11% below MO's 3 year average," as more compelling and offering a “more balanced risk-reward” – and cites the underperformance as a key reason behind rating upgrade.
The analyst also weighed in on by far the biggest issue surrounding the company in recent days – the FDA’s marketing denial order of the popular Juul line of products.
On that front, she notes that, unlike other companies who usually kept selling products while appealing denial orders, “JUUL may have a harder time remaining on the shelf given the FDA's toxicological concerns and the agency's indication that it may take enforcement action against retailers/distributors who continue to sell.”
To account for the risk, Morgan Stanley chose to "eliminate JUUL from our base case, reflect increasing investment needs behind RRPs, and greater long-term risk around MO's growth outlook", and lower the Price Target to $43 from $47.
Shares of MO closed at $42.51 yesterday, in line with the analyst’s expectations.
BERLIN (Reuters) -The economic outlook for Germany is gloomy due to energy price rises and supply chain disruptions, the finance ministry said on Friday, a message underscored by...
By Huw Jones LONDON (Reuters) - Britain's financial watchdog has told firms offering 'buy now, pay later' loans to spell out the cost of late repayments to customers as the UK...
(This content was produced in Russia where the law restricts coverage of Russian military operations in Ukraine) MOSCOW (Reuters) - The rouble firmed to a near four-week high...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.